RAYMOND JAMES FINANCIAL INC
Position in AKBA — Akebia Therapeutics, Inc.
CIK 720005
ST. PETERSBURG, FL
Position in AKBA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$101,333
-$28,395 QoQ
Shares Held
72,902
-9.5% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026RAYMOND JAMES FINANCIAL INC holds $783,930,823 across 37 Drug Manufacturers - Specialty & Generic names. AKBA ranks #32 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,166,615 | $374,325,557 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
601,487 | $79,239,894 | |
| 3 | HLN |
Haleon plc
|
6,264,041 | $62,703,048 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,816,715 | $54,719,453 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
1,898,337 | $45,427,201 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
556,460 | $32,981,383 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
47,576 | $28,211,615 | |
| 8 | VTRS |
Viatris Inc
|
1,855,553 | $25,068,518 |
All Filings in AKBA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $101,333 | 72,902 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $129,728 | 80,577 | Shares | Defined | 2026-02-18 | |
| 2025-09-30 | $190,512 | 69,785 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $216,586 | 59,502 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $97,793 | 50,934 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $85,020 | 44,748 | Shares | Defined | 2025-04-23 | |
| No filing history on record for this holder in this stock. | ||||||